Trade Amgen AMGN

Sell
 Buy

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Amgen News

Oil Price Forecast 2026
Daniel Carter 2026 Oct 27, 16:03

Oil Price Forecast 2026–2030: What UAE Traders Should Watch

silver price prediction aed
Daniel Carter 2026 Oct 27, 16:03

Silver Price Prediction 2026–2030: What Could Silver Cost in the UAE?

Julian Parker 2026 Oct 22, 16:04

AED to INR Forecast 2026–2030: What Could Move the Rupee?

Julian Parker 2026 Oct 21, 16:04

GBP to AED Forecast 2026–2030: What Could Move the Pound Against the Dirham?

usd to aed forecast
Daniel Carter 2026 Oct 20, 16:03

USD to AED Forecast 2026–2030: Will the Dirham Stay Near 3.6725?

cfd-trade
Julian Parker 2026 Oct 20, 16:03

Best Stocks to Buy in UAE: 7 Companies to Watch and Compare

gold price trend 2024 to 2026 analysis facts
2026 Aug 24, 16:03

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Best Broker in the UAE With a Welcome Bonus
2026 Aug 12, 16:03

Best CFD Brokers in the UAE with Welcome Bonuses in 2026

markets.com
2026 Jul 16, 16:03

Markets.com Review 2026: Is It the Best CFD Trading Platform?

Latest news

Show more
Julian Parker 2026 Oct 27, 16:05

Dubai’s Shangri-La Hotel Set for $1.3 Billion AHS Twin Towers Office Conversion

Julian Parker 2026 Oct 27, 16:04

Dubai Fuel Prices Stay Above AED4 as Motorists Await November Update

Julian Parker 2026 Oct 27, 16:03

Oil Price Today UAE: Brent Tops $115 as Saudi Attack Claim Renews Gulf Supply Concerns

gold rate in UAE today
Daniel Carter 2026 Oct 27, 16:03

Gold Rate in UAE Today Rises to AED 489 as Bullion Holds Above $4,050 Before the Fed

UAE Interest Rate
Daniel Carter 2026 Oct 27, 16:03

UAE Interest Rate Today: Will the CBUAE Hold Its Base Rate at 3.90% After the Fed Decision?

Julian Parker 2026 Oct 26, 16:04

UAE Faces Travel and Energy Cost Risks as Iran Diplomacy Continues

Bitcoin price AED
Daniel Carter 2026 Oct 26, 16:02

Bitcoin Price in UAE Holds Near AED 292,500 as Fed Uncertainty Limits the Recovery

aed to inr
Daniel Carter 2026 Oct 26, 16:02

AED to INR Holds Near 25.90 Before the Fed Decision: Is 26.00 Back in Sight?

Info

Spread

2.72

Spread (%)

0.6051 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Wednesday

13:31 - 19:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

240381214720

Shares Outstanding

540632005

Earnings Date (Next)

1999-11-22

Div Yield

2026-09-11

Ex-Dividend Date

2026-08-21

Forward annual dividend rate

10.08

Forward annual dividend yield

0.0227

EPS

16.1

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Oct 27, 16:04

Best Energy Stocks to Buy in the United Arab Emirates: Top Companies Compared

Julian Parker 2026 Oct 26, 16:03

How Forex Works: A Beginner’s Guide for UAE Traders

anthropic ipo how to invest in uae
Daniel Carter 2026 Oct 26, 16:03

How to Invest in Anthropic IPO From the UAE? [2026 Guide]

Trustpilot